Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 4
2017 2
2018 3
2019 3
2020 4
2021 6
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.
Garin E, Tselikas L, Guiu B, Chalaye J, Edeline J, de Baere T, Assenat E, Tacher V, Robert C, Terroir-Cassou-Mounat M, Mariano-Goulart D, Amaddeo G, Palard X, Hollebecque A, Kafrouni M, Regnault H, Boudjema K, Grimaldi S, Fourcade M, Kobeiter H, Vibert E, Le Sourd S, Piron L, Sommacale D, Laffont S, Campillo-Gimenez B, Rolland Y; DOSISPHERE-01 Study Group. Garin E, et al. Among authors: chalaye j. Lancet Gastroenterol Hepatol. 2021 Jan;6(1):17-29. doi: 10.1016/S2468-1253(20)30290-9. Epub 2020 Nov 7. Lancet Gastroenterol Hepatol. 2021. PMID: 33166497 Free article. Clinical Trial.
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux GP, Sibert A, Bouattour M, Lebtahi R, Allaham W, Barraud H, Laurent V, Mathias E, Bronowicki JP, Tasu JP, Perdrisot R, Silvain C, Gerolami R, Mundler O, Seitz JF, Vidal V, Aubé C, Oberti F, Couturier O, Brenot-Rossi I, Raoul JL, Sarran A, Costentin C, Itti E, Luciani A, Adam R, Lewin M, Samuel D, Ronot M, Dinut A, Castera L, Chatellier G; SARAH Trial Group. Vilgrain V, et al. Lancet Oncol. 2017 Dec;18(12):1624-1636. doi: 10.1016/S1470-2045(17)30683-6. Epub 2017 Oct 26. Lancet Oncol. 2017. PMID: 29107679 Clinical Trial.
Non-invasive diagnosis and follow-up of primary malignant liver tumours.
Nahon P, Aubé C, Moga L, Chalaye J, Guiu B, Luciani A, Rode A, Ronot M, Seror O, Soussan M, Sutter O, Bourlière M, Bureau C, de Lédinghen V, Ganne-Carrié N. Nahon P, et al. Among authors: chalaye j. Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101766. doi: 10.1016/j.clinre.2021.101766. Epub 2021 Jul 29. Clin Res Hepatol Gastroenterol. 2022. PMID: 34332137
Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 Trial.
Garin E, Tselikas L, Guiu B, Chalaye J, Rolland Y, de Baere T, Assenat E, Tacher V, Palard X, Déandreis D, Mariano-Goulart D, Amaddeo G, Boudjema K, Hollebecque A, Meerun MA, Regnault H, Vibert E, Campillo-Gimenez B, Edeline J. Garin E, et al. Among authors: chalaye j. J Nucl Med. 2024 Feb 1;65(2):264-269. doi: 10.2967/jnumed.123.266211. J Nucl Med. 2024. PMID: 38212068 Free PMC article. Clinical Trial.
[18F]-NaF PET/CT imaging in cardiac amyloidosis.
Van Der Gucht A, Galat A, Rosso J, Guellich A, Garot J, Bodez D, Plante-Bordeneuve V, Hittinger L, Dubois-Randé JL, Evangelista E, Sasanelli M, Chalaye J, Meignan M, Itti E, Damy T. Van Der Gucht A, et al. Among authors: chalaye j. J Nucl Cardiol. 2016 Aug;23(4):846-9. doi: 10.1007/s12350-015-0287-0. Epub 2015 Sep 24. J Nucl Cardiol. 2016. PMID: 26403145
FDG PET/CT of Cervical Gout With Spinal Cord Compression.
Emsen B, Fitoussi A, Chalaye J, Adam C, Itti E. Emsen B, et al. Among authors: chalaye j. Clin Nucl Med. 2020 Jan;45(1):e29-e31. doi: 10.1097/RLU.0000000000002772. Clin Nucl Med. 2020. PMID: 31652157
Utility of Early Posttreatment PET/CT Evaluation Using FDG or 18F-FCH to Predict Response to 90Y Radioembolization in Patients With Hepatocellular Carcinoma.
Reizine E, Chalaye J, Mule S, Regnault H, Perrin C, Calderaro J, Laurent A, Amaddeo G, Kobeiter H, Tacher V, Itti E, Luciani A. Reizine E, et al. Among authors: chalaye j. AJR Am J Roentgenol. 2022 Feb;218(2):359-369. doi: 10.2214/AJR.21.26485. Epub 2021 Sep 8. AJR Am J Roentgenol. 2022. PMID: 34494448
Chest PET/MRI in Solid Cancers: Comparing the Diagnostic Performance of a Free-Breathing 3D-T1-GRE Stack-of-Stars Volume Interpolated Breath-Hold Examination (StarVIBE) Acquisition With That of a 3D-T1-GRE Volume Interpolated Breath-Hold Examination (VIBE) for Chest Staging During Whole-Body PET/MRI.
Vermersch M, Emsen B, Monnet A, Chalaye J, Galletto Pregliasco A, Baranes L, Rahmouni A, Luciani A, Itti E, Mulé S. Vermersch M, et al. Among authors: chalaye j. J Magn Reson Imaging. 2022 Jun;55(6):1683-1693. doi: 10.1002/jmri.27981. Epub 2021 Nov 3. J Magn Reson Imaging. 2022. PMID: 34730867
Accuracy and reproducibility of a cone beam CT-based virtual parenchymal perfusion algorithm in the prediction of SPECT/CT anatomical and volumetric results during the planification of radioembolization for HCC.
Derbel H, Krichen M, Chalaye J, Saccenti L, Van der Sterren W, Muris AH, Lerman L, Galletto A, Zaarour Y, Luciani A, Kobeiter H, Tacher V. Derbel H, et al. Among authors: chalaye j. Eur Radiol. 2023 May;33(5):3510-3520. doi: 10.1007/s00330-023-09390-w. Epub 2023 Jan 18. Eur Radiol. 2023. PMID: 36651956
23 results